infostations

The amount in external funding for research and other sponsored programs at West Virginia University for fiscal year 2021 tops the previous year’s record by $8 million.

Legendary West Virginia University linebacker Sam Huff died Saturday, Nov. 13, in Winchester, Virginia, following years of declining health. President Gordon Gee joined Director of Athletics Shane Lyons in paying homage to Huff.

University Police identified two juvenile suspects over the weekend and the department is working with prosecutors on charges for the teenage girls (not WVU students) related to Friday’s reported arson at the Mountainlair.

In a new study, Sunil Sharma, a researcher in WVU's School of Medicine, found that rural COVID patients who end up in an intensive care unit face a greater risk of death than their urban counterparts do. He also discovered that rural patients with COVID-linked acute respiratory distress syndrome are more likely to die than patients with ARDS that’s due to another cause.

West Virginia University will launch several projects and programs designed to address challenges facing rural Appalachia — everything from small-scale farming to supporting the state’s aging population.

Angie Macias, a doctoral student, and Matt Kasson, associate professor, are part of a National Geographic-funded project to study the fungal diversity associated with fungus-feeding millipedes.

A 39-foot customized Winnebago will serve as a medical clinic on wheels in even the most hard-to-reach areas of the state.

President Gordon Gee sent a letter to West Virginia University faculty, staff, students, alumni and friends on Monday, Nov. 8 to address concerns raised by his advisory role at the University of Austin noting this opportunity highlights how transformation across the WVU System can help lift all of higher education.

Future teachers training at West Virginia University will benefit from a $1 million scholarship gift made in memory of a dedicated educator and devoted WVU alumna.

Uveal melanoma may be a rare form of cancer, but it’s almost always fatal. No treatments currently available for it can significantly lengthen someone’s life. WVU School of Pharmacy researcher Mark McLaughlin and his colleagues are working to change that. The Food and Drug Administration recently approved a clinical trial of their new drug that precisely targets uveal melanoma, even after the cancer has spread to other parts of the body.